SARS-CoV-2 variants of concern continue to emerge, reducing vaccine efficacy and limiting therapeutic options. Here, Chen and colleagues describe the identification and design of shark nanobodies with pansarbecovirus activity.
- Wei-Hung Chen
- Agnes Hajduczki
- M. Gordon Joyce
